Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

American Gastroenterological Association medical position statement: diagnosis and treatment of hemorrhoids.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, the Clinical Practice Committee meets three times a year to review all American Gastroenterological Association Institute (AGAI) guidelines. This review includes new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Hemorrhoids are a common affliction in the adult population. Symptoms include bleeding, pain, protrusion, and itching. However, because none of these symptoms are specific for hemorrhoids, the diagnosis should only be made after an appropriate physical examination has ruled out other disorders, such as anal fissure, fistula, or abscess.

Hemorrhoids are optimally visualized using an anoscope. Hemorrhoidal bleeding is bright red and can appear as scanty blood on the toilet paper or copious blood squirting into the toilet bowl. All patients who report rectal bleeding should undergo sigmoidoscopy. The proximal colon should be evaluated by colonoscopy or air-contrast barium enema to assess bleeding that is not typical of hemorrhoids (e.g., dark blood or blood mixed in the feces), guaiac-positive stools, or anemia. The individual patient’s risk factors for colorectal cancer (age, family history, or personal history of polyps) should also be considered when deciding on the extent of colonic evaluation.

Internal hemorrhoids are classified according to the symptoms they cause. In the most commonly used classification, first-degree hemorrhoids bleed but do not protrude, second-degree hemorrhoids protrude with defecation but reduce spontaneously, third-degree hemorrhoids protrude and require digital reduction, and fourth-degree hemorrhoids cannot be reduced. External hemorrhoids usually do not cause symptoms unless thrombosis occurs, in which case the patient experiences acute pain.

Treatment of hemorrhoids depends on their severity. Medical therapy is most appropriate for first-degree hemorrhoids. The cornerstone of medical therapy is adequate intake of fiber and water. Topical corticosteroids and analgesics are useful for managing perianal skin irritation due to poor hygiene, mucus discharge, or fecal seepage. Prolonged use of potent corticosteroid preparations may be harmful and should be avoided.

Nonoperative techniques for ablating hemorrhoids include injection sclerotherapy, diathermy coagulation, bipolar coagulation, infrared coagulation, and rubber band ligation. Cryotherapy has a high complication rate and is no longer recommended. Nonoperative techniques are most appropriate for second- and third-degree hemorrhoids but are also indicated when medical treatment of first-degree hemorrhoids has failed. Each of these therapies can be used for outpatients and may be repeated as needed; none require anesthesia. Complications are infrequent and usually minor; however, immunocompromised patients are at an increased risk for severe infection, particularly after rubber band ligation. Choice of individual technique depends in part on the physician’s training, experience, and preference. Meta-analyses of nonoperative therapy show that patients who undergo sclerotherapy (used only for first- and second-degree hemorrhoids) have a relatively high relapse rate and that rubber band ligation causes relatively more discomfort than other techniques. However, postbanding pain is usually minor and rubber band ligation is associated with the lowest recurrence rate of the nonoperative techniques.

If diagnosed early, thrombosed external hemorrhoids are best managed by excision under local anesthesia in the office or clinic. Excision is not required for patients whose symptoms are resolving, because the pain associated with hemorrhoidal thrombosis typically resolves after 7–10 days.

Hemorrhoidectomy, the most effective treatment for hemorrhoids, is associated with significantly more pain and complications than nonoperative techniques. Accordingly, surgery should be recommended only for a small minority of patients. Indications for elective hemorrhoidectomy include the following: (1) failure of medical and nonoperative therapy; (2) symptomatic third-degree, fourth-degree, or mixed internal and external hemorrhoids; (3) symptomatic hemorrhoids in the presence of a concomitant anorectal condition that requires surgery; and (4) patient preference, after discussion of treatment options with the referring physician and surgeon. A number of operative techniques are acceptable for hemorrhoidectomy, depending on the surgeon’s training, experience, and preference. Manual dilatation of the anus is not recommended, given the associated risk of sphincter injury and incontinence. Laser hemorrhoidectomy has no advantage over hemorrhoidectomy using conventional techniques and is more costly. Stapled hemorrhoidectomy is a relatively new procedure that is associated with significantly less pain than conventional hemorrhoidectomy. Results appear comparable to conventional hemorrhoidectomy, although follow-up is relatively short to date and a small number of serious complications have been reported. Patients with acutely prolapsed, incarcerated, and thrombosed hemorrhoids should undergo either hemorrhoidectomy or excision of the external component with rubber band ligation of the internal hemorrhoids.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based upon the interpretation and assimilation of scientifically valid research, derived from a comprehensive review of published literature. Ideally, the intent is to provide evidence based upon prospective, randomized placebo-controlled trials; however, when this is not possible the use of experts’ consensus may occur.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2004 May

GUIDELINE DEVELOPER(S)

American Gastroenterological Association Institute - Medical Specialty Society

SOURCE(S) OF FUNDING

American Gastroenterological Association Institute

GUIDELINE COMMITTEE

American Gastroenterological Association Clinical Practice Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

According to the guideline developer, the Clinical Practice Committee meets three times a year to review all American Gastroenterological Association Institute (AGAI) guidelines. This review includes new literature searches of electronic databases followed by expert committee review of new evidence that has emerged since the original publication date.

GUIDELINE AVAILABILITY

Electronic copies: Available from the American Gastroenterological Association Institute (AGAI) Gastroenterology journal Web site.

Print copies: Available from the American Gastroenterological Association Institute, 4930 Del Ray Avenue, Bethesda, MD 20814.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on August 24, 2004.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo